These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 21593228

  • 21. Safety of a new oral contraceptive containing drospirenone.
    Heinemann LA, Dinger J.
    Drug Saf; 2004; 27(13):1001-18. PubMed ID: 15471507
    [Abstract] [Full Text] [Related]

  • 22. Drospirenone Litigation: Does the Punishment Fit the Crime?
    Batur P, Casey PM.
    J Womens Health (Larchmt); 2017 Feb; 26(2):99-102. PubMed ID: 27854556
    [Abstract] [Full Text] [Related]

  • 23. Drospirenone and VTE.
    Leppée M, Eric M, Culig J.
    J Fam Plann Reprod Health Care; 2010 Jan; 36(1):44. PubMed ID: 20067674
    [No Abstract] [Full Text] [Related]

  • 24. Drospirenone-containing combined oral contraceptives and the risk of arterial thrombosis: a population-based nested case-control study.
    Larivée N, Suissa S, Eberg M, Joseph L, Eisenberg MJ, Abenhaim HA, Filion KB.
    BJOG; 2017 Oct; 124(11):1672-1679. PubMed ID: 27704723
    [Abstract] [Full Text] [Related]

  • 25. Type of Combined Contraceptives, Factor V Leiden Mutation and Risk of Venous Thromboembolism.
    Hugon-Rodin J, Horellou MH, Conard J, Gompel A, Plu-Bureau G.
    Thromb Haemost; 2018 May; 118(5):922-928. PubMed ID: 29614525
    [Abstract] [Full Text] [Related]

  • 26. Oral contraceptives and venous thromboembolism: consensus conference statement.
    Dialogues in Contraception Consensus Conference (1995: Chicago).
    Dialogues Contracept; 1996 May; ():1-8. PubMed ID: 12320455
    [Abstract] [Full Text] [Related]

  • 27. Oral contraceptives and venous thromboembolism: pill scares and public health.
    Reid RL.
    J Obstet Gynaecol Can; 2011 Nov; 33(11):1150-5. PubMed ID: 22082790
    [Abstract] [Full Text] [Related]

  • 28. SOGC clinical practice guideline. No. 252, December 2010. Oral contraceptives and the risk of venous thromboembolism: an update.
    Reid R, CLINICAL PRACTICE GYNAECOLOGY COMMITTEE.
    J Obstet Gynaecol Can; 2010 Dec; 32(12):1192-1197. PubMed ID: 21176332
    [Abstract] [Full Text] [Related]

  • 29. The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation.
    Dinger JC, Heinemann LA, Kühl-Habich D.
    Contraception; 2007 May; 75(5):344-54. PubMed ID: 17434015
    [Abstract] [Full Text] [Related]

  • 30. Risk of thromboembolism in women taking ethinylestradiol/drospirenone and other oral contraceptives.
    Seeger JD, Loughlin J, Eng PM, Clifford CR, Cutone J, Walker AM.
    Obstet Gynecol; 2007 Sep; 110(3):587-93. PubMed ID: 17766604
    [Abstract] [Full Text] [Related]

  • 31. Oral contraceptives and venous thromboembolism: a systematic review and meta-analysis.
    Manzoli L, De Vito C, Marzuillo C, Boccia A, Villari P.
    Drug Saf; 2012 Mar 01; 35(3):191-205. PubMed ID: 22283630
    [Abstract] [Full Text] [Related]

  • 32. [Venous thromboembolism in adolescents associated with fourth-generation oral contraceptives].
    Botzenhardt S, Toni I, Rascher W, Neubert A.
    Klin Padiatr; 2013 Sep 01; 225(5):268-76. PubMed ID: 23979828
    [Abstract] [Full Text] [Related]

  • 33. Venous thromboembolism and combined oral contraceptives: does the type of progestogen make a difference?
    Lawrenson R, Farmer R.
    Contraception; 2000 Aug 01; 62(2 Suppl):21S-28S; discussion 37S-38S. PubMed ID: 11102599
    [Abstract] [Full Text] [Related]

  • 34. Epidemiology of hormonal contraceptives-related venous thromboembolism.
    Hugon-Rodin J, Gompel A, Plu-Bureau G.
    Eur J Endocrinol; 2014 Dec 01; 171(6):R221-30. PubMed ID: 25012200
    [Abstract] [Full Text] [Related]

  • 35. Combined hormonal contraceptives and venous thromboembolism: putting the risks into perspective.
    Raymond EG, Burke AE, Espey E.
    Obstet Gynecol; 2012 May 01; 119(5):1039-44. PubMed ID: 22525916
    [Abstract] [Full Text] [Related]

  • 36. ACOG Committee Opinion Number 540: Risk of venous thromboembolism among users of drospirenone-containing oral contraceptive pills.
    Committee on Gynecologic Practice.
    Obstet Gynecol; 2012 Nov 01; 120(5):1239-42. PubMed ID: 23090561
    [Abstract] [Full Text] [Related]

  • 37. Combined hormonal contraceptives and the risk of venous and arterial thromboembolism and cardiovascular death: misuse of automated databases.
    Shapiro S.
    J Fam Plann Reprod Health Care; 2013 Apr 01; 39(2):89-96. PubMed ID: 23493593
    [Abstract] [Full Text] [Related]

  • 38. Higher risk of venous thrombosis associated with drospirenone-containing oral contraceptives: a population-based cohort study.
    Gronich N, Lavi I, Rennert G.
    CMAJ; 2011 Dec 13; 183(18):E1319-25. PubMed ID: 22065352
    [Abstract] [Full Text] [Related]

  • 39. Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis.
    Martínez F, Ramírez I, Pérez-Campos E, Latorre K, Lete I.
    Eur J Contracept Reprod Health Care; 2012 Feb 13; 17(1):7-29. PubMed ID: 22239262
    [Abstract] [Full Text] [Related]

  • 40. Oral contraceptive use and venous thromboembolism: a consideration of the impact of bias and confounding factors on epidemiological studies.
    Rekers H, Norpoth T, Michaels MA.
    Eur J Contracept Reprod Health Care; 1996 Feb 13; 1(1):21-30. PubMed ID: 9678134
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.